SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-027837
Filing Date
2023-08-11
Accepted
2023-08-11 16:16:18
Documents
48
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 807076
2 ex31-1.htm EX-31.1 17794
3 ex31-2.htm EX-31.2 18225
4 ex32-1.htm EX-32.1 7021
5 ex32-2.htm EX-32.2 7116
  Complete submission text file 0001493152-23-027837.txt   4040369

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hils-20230630.xsd EX-101.SCH 27306
7 XBRL CALCULATION FILE hils-20230630_cal.xml EX-101.CAL 32723
8 XBRL DEFINITION FILE hils-20230630_def.xml EX-101.DEF 142101
9 XBRL LABEL FILE hils-20230630_lab.xml EX-101.LAB 265419
10 XBRL PRESENTATION FILE hils-20230630_pre.xml EX-101.PRE 220580
42 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 485414
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Hillstream BioPharma Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41210 | Film No.: 231164333
SIC: 2834 Pharmaceutical Preparations